Saflutan
Saflutan is a medicine authorised by Swissmedic under authorisation number 67174. The authorisation holder is Santen SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 August 2019 and the authorisation is valid without a time limit. ATC code S01EE05 places the medicine in the group Ophthalmologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Saflutan, collyre (multidose) | B | 20 August 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 3 | ml | S01EE05 | 11.09.0. | B |
| 2 | 3 x 3 | ml | S01EE05 | 11.09.0. | B |
| 3 | 1 x 5 | ml | S01EE05 | 11.09.0. | B |
| 4 | 1 x 7 | ml | S01EE05 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Saflutan authorised in Switzerland?
Yes. Saflutan is authorised by Swissmedic under authorisation number 67174, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Saflutan have?
Saflutan is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Saflutan?
The authorisation holder is Santen SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.